Effectiveness of Intra-Aortic Ballooning Occlusion for Bleeding Control in Gravida Patients with Placenta Accreta

Monica Bellynda; Erwin Aritama Ismail; Andhika Aji Nugroho; Muhammad Fahmi Salafuddin; Muhammad Rizki Kamil; Darmawan Ismail

doi:10.3889/oamjms.2022.9711

Authors

Monica Bellynda Department of Surgery, Medical Faculty, Universitas Sebelas Maret, Surakarta, Indonesia
Erwin Aritama Ismail Department of Surgery, Medical Faculty, Universitas Sebelas Maret, Surakarta, Indonesia
Andhika Aji Nugroho Department of Surgery, Medical Faculty, Universitas Sebelas Maret, Surakarta, Indonesia
Muhammad Fahmi Salafuddin Department of Surgery, Medical Faculty, Universitas Sebelas Maret, Surakarta, Indonesia
Muhammad Rizki Kamil Research Assistant, Medical Faculty,Universitas Sebelas Maret, Surakarta, Indonesia
Darmawan Ismail Department of Cardiothoracic and Vascular Surgery, Medical Faculty, Universitas Sebelas Maret, Surakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9711

Keywords:

Clinical outcome, Placenta accrete, Intra-aortic ballooning occlusion

Abstract

Introduction:

Placenta previa and morbidly adherent placenta cause significant maternal morbidity and mortality from postpartum hemorrhage. Intra-aortic balloon occlusion has been shown to reduce intraoperative hemorrhage effectively.

Cases Presentation

We reported four cases of women who underwent cesarean section and hysterectomy with IABO. All four were multigravida, gestational age range was 37-39 weeks, MAP score range 6-8. Ultrasound examination showed placenta accreta. After the cesarean section and hysterectomy procedure with IABO, the bleeding was 600-800 cc.

Conclusions

Intra-Aortic Ballooning Occlusion is an effective method to reduce bleeding complications during and after cesarean section in pregnancies with placenta accreta.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Berg CJ, Atrash HK, Koonin LM. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol. 1996;88(2):161-7. https://doi.org/10.1016/0029-7844(96)00135-4 PMid:8692494 DOI: https://doi.org/10.1016/0029-7844(96)00135-4

Hayes E, Ayida G, Crocker A. The morbidly adherent placenta: Diagnosis and management options. Curr Opin Obstet Gynecol. 2011;23(6):448-53. https://doi.org/10.1097/GCO.0b013e32834cef7a PMid:22002113 DOI: https://doi.org/10.1097/GCO.0b013e32834cef7a

Royal College of Obstetricians and Gynaecologists. Placenta Praevia, Placenta Praevia Accreta, and Vasa Praevia: Diagnosis and Management: Green-top Guideline No. 27. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg27placentapraeviajanuary2011.pdf [Last accessed on 2014 Aug 15].

Blumenthal E, Rao R, Murphy A, Gornbein J, Hong R, Moriarty J, et al. Pilot study of intra-aortic balloon occlusion to limit morbidity in patients with adherent placentation undergoing cesarean hysterectomy. AJP Rep. 2018;8(2):e57-63. https://doi.org/10.1055/s-0038-1641736 DOI: https://doi.org/10.1055/s-0038-1641736

Kidney DD, Nguyen AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. AJR Am J Roentgenol. 2001;176(6):1521-4. https://doi.org/10.2214/ajr.176.6.1761521 PMid:11373225 DOI: https://doi.org/10.2214/ajr.176.6.1761521

Masamoto H, Uehara H, Gibo M, Okubo E, Sakumoto K, Aoki Y. Elective use of aortic balloon occlusion in cesarean hysterectomy for placenta previa percreta. Gynecol Obstet Invest. 2009;67(2):92-5. https://doi.org/10.1159/000164685 PMid:18936549 DOI: https://doi.org/10.1159/000164685

Makary M, Chowdary P, Westgate JA. Vascular balloon occlusion and planned caesarean hysterectomy for morbidly adherent placenta: A systematic review. Aust New Zeal J Obstet Gynaecol. 2019;59(5):608-15. https://doi.org/10.1111/ajo.13027 PMid:31281966 DOI: https://doi.org/10.1111/ajo.13027

Wortman AC, Alexander JM. Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2013;40(1):137-54. https://doi.org/10.1016/j.ogc.2012.12.002 PMid:23466142 DOI: https://doi.org/10.1016/j.ogc.2012.12.002

Kayem G, Davy C, Goffinet F, Thomas C, Clement D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004;104(3):531-6. https://doi.org/10.1097/01.AOG.0000136086.78099.0f PMid:15339764 DOI: https://doi.org/10.1097/01.AOG.0000136086.78099.0f

Bretelle F, Courbiere B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: Morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007;133(1):34-9. https://doi.org/10.1016/j.ejogrb.2006.07.050 PMid:16965851 DOI: https://doi.org/10.1016/j.ejogrb.2006.07.050

Chan BC, Lam HS, Yuen JH, Lam TP, Tso WK, Pun TC, et al. Conservative management of placenta praevia with accreta. Hong Kong Med J. 2008;14(6):479-84. PMid:19060348

Mazouni C, Palacios-Jaraquemada JM, Deter R, Juhan V, Gamerre M, Bretelle F. Differences in the management of suspected cases of placenta accreta in France and Argentina. Int J Gynaecol Obstet. 2009;107(1):1-3. https://doi.org/10.1016/j.ijgo.2009.04.021 PMid:19477444 DOI: https://doi.org/10.1016/j.ijgo.2009.04.021

Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648-54. https://doi.org/10.1111/j.1471-0528.2008.02037.x PMid:19191778 DOI: https://doi.org/10.1111/j.1471-0528.2008.02037.x

Gielchinsky Y, Rojansky W, Fasouliotis SJ, Ezra Y. Placenta accreta--summary of 10 years: A survey of 310 cases. Placenta. 2002;23(2):210-4. https://doi.org/10.1053/plac.2001.0764 PMid:11945088 DOI: https://doi.org/10.1053/plac.2001.0764

Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat caesarean deliveries. Obstet Gynecol. 2006;107(6):1226-32. https://doi.org/10.1097/01.AOG.0000219750.79480.84 PMid:16738145 DOI: https://doi.org/10.1097/01.AOG.0000219750.79480.84

Wang YL, Su FM, Zhang HY, Wang F, Zhe RL, Shen XY. Aortic balloon occlusion for controlling intraoperative hemorrhage in patients with placenta previa increta/percreta. J Matern Neonatal Med. 2017;30(21):2564-8. https://doi.org/10.1080/14767058.2016.1256990 PMid:28264601 DOI: https://doi.org/10.1080/14767058.2016.1256990

Sumigama S, Itakura A, Ota T, Okada M, Kotani T, Hayakawa H, et al. Placenta previa increta/percreta in Japan: A retrospective study of ultrasound findings, management and clinical course. J Obstet Gynaecol Res. 2007;33(5):606-11. https://doi.org/10.1111/j.1447-0756.2007.00619.x PMid:17845316 DOI: https://doi.org/10.1111/j.1447-0756.2007.00619.x

Wang YL, Duan XH, Han XW. Temporary aortic balloon occlusion in management of cesarean section for pernicious placenta previa/accreta. J Pract Radiol. 2015;7:1186-8.

Liu C, Zhao XL. The application of temporary ballon occlusion of the abdominal aorta in patients with pernicious placenta previa and placenta accreta. J Pract Obstet Gynecol. 2016;32(3):204-7.

Zhou Y, Yang Y, Huang Y. The application of temporary ballon occlusion of the abdominal aorta in pernicious placenta previa. Fujian Med J. 2014;36(6):22-4.

Gan B. Clinical analysis of distal abdominal preoperative balloon occlusion for the treatment of dangerous placenta previa. Chinese Foreign Med Res. 2015;13(4):148-9.

Tatli E, Buturak A, Grunduz Y, Dogan E, Alkan M, Sayin M, et al. Comparison of anti-embolic protection with proximal balloon occlusion and filter devices during carotid artery stenting: Clinical and procedural outcomes. Postepy Kardiol Interwencyjnej. 2013;9(3):221-7. https://doi.org/10.5114/pwki.2013.37499 PMid:24570722 DOI: https://doi.org/10.5114/pwki.2013.37499